Ramya Ramasubramanian
Education
Ph.D., M.P.H., epidemiology, University of Minnesota; B. Tech., biotechnology, SASTRA University, Tamil Nadu, India
Summary of Experience
Dr. Ramasubramanian specializes in epidemiology and health economics and outcomes research (HEOR), with experience evaluating clinical outcomes, healthcare resource utilization, and treatment patterns across multiple therapeutic areas, including oncology, cardiovascular diseases, obesity, and rare diseases. She applies epidemiologic and quantitative methods to generate real-world evidence that informs health care decision making. She has experience with diverse real-world data sources, including administrative claims, electronic health records, medical-chart reviews, hospital-based data, and specialty pharmacy data, to assess disease burden, treatment effectiveness, and economic outcomes. Her research has been presented at conferences and published in peer-reviewed journals.
-
Attack Rate Reductions Following Berotralstat Initiation Among US Patients With Hereditary Angioedema in the Real-World
Allergy, Asthma & Clinical Immunology, 2025
2025Davis-Lorton M, Tachdjian R, Lopez-Gonzalez L, MacKnight SD, Ramasubramanian R, Laliberté F, Gillard P, LiVecchi M, Nestler-Parr S, Lumry WR
-
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma
Clinical Lymphoma, Myeloma & Leukemia, 2025
2025Nastoupil LJ, Andersen CR, Ayers A, Wang Y, Habermann TM, Chihara D, Kahl BS, Link BK, Koff JL, Cohen JB, Martin P, Lossos IS, Stanchina M, Haddadi S, Casulo C, Ayyappan S, Lin R, Li Z, Larson MA, Maurer MJ, Huynh L, Gao C, Ramasubramanian R, Duh MS, Mutebi A, Wang T, Jun M, Wang A, Kamalakar R, Kalsekar A, Cerhan JR, Flowers CR
-
Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS)
Orphanet Journal of Rare Diseases, 2025
2025Mahendran M, Upton JEM, Ramasubramanian R, Memmott HL, Germain G, Büsch K, Laliberté F, Harrington A
-
Mepolizumab for the management of chronic rhinosinusitis with nasal polyps across the United States: A retrospective study
Journal of Allergy and Clinical Immunology, 2025
2025Cardet JC, Silver J, Maldonado-Puebla M, Laliberté F, Gao C, Ramasubramanian R, Hilts A, Zhang K, Hwee J, Ahmed W, Edgecomb AG
-
February 4, 2026
-
April 11, 2024
-
December 1, 2023